filmarray
bd
max
bd
diagnost
luminex
nextgener
sequenc
conclus
clinic
microbiolog
laboratori
constantli
evolv
progress
new
technolog
revolution
character
diagnosi
pathogen
purpos
chapter
review
featur
benefit
limit
key
new
methodolog
infecti
diseas
diagnost
chapter
organ
technolog
new
technolog
impact
field
bacteriolog
virolog
also
promis
new
develop
mycolog
parasitolog
mainstay
bacteri
mycolog
diagnosi
continu
cultur
tradit
techniqu
although
increasingli
autom
fig
organ
isol
howev
host
newer
diagnost
enhanc
case
replac
biochem
test
algorithm
histor
defin
clinic
bacteriolog
advent
matrixassist
laser
desorpt
time
flight
malditof
mass
spectrometri
one
main
forc
behind
shift
allow
cultur
organ
identifi
minut
instead
hour
day
even
week
case
slowgrow
organ
mycobacteria
although
still
routin
clinic
use
applic
malditof
direct
patient
sampl
blood
urin
applic
antibiot
resist
excit
develop
beyond
bacteria
malditof
becom
establish
identif
yeast
develop
extens
higher
qualiti
librari
expect
also
fungi
nucleic
acidbas
technolog
also
big
impact
particular
grow
number
test
platform
provid
rapid
diagnost
directli
primari
specimen
mani
multiplex
look
sever
pathogen
one
time
sequenc
region
ribosom
rna
rrna
rrna
gene
bacteria
alreadi
consid
gold
standard
bacteri
identif
enter
clinic
diagnost
fig
similarli
routin
sequenc
intergen
transcrib
spacer
rrna
region
fungi
welcom
addit
current
labori
morphologyheavi
techniqu
diagnos
fungal
ill
entri
nextgener
sequenc
ng
clinic
microbiolog
also
dramat
effect
profil
individu
specimen
ie
member
potenti
outbreak
highli
drug
resist
strain
well
commun
ie
microbiom
analysi
health
diseas
final
emerg
technolog
polymeras
chain
reaction
pcr
electrospray
ioniz
esi
mass
spectrometri
hold
great
promis
major
phyla
pathogen
test
immunohistochemistri
ihc
anatom
patholog
base
principl
rapid
test
wide
rang
use
detect
sometim
speciat
organ
formalinfix
paraffinembed
tissu
ffpe
section
organ
commonli
identifi
way
includ
spirochet
mycobacteria
dna
virus
aspergillu
candida
toxoplasma
although
special
refer
laboratori
eg
infecti
diseas
patholog
branch
center
diseas
control
prevent
wide
rang
antibodi
common
exot
pathogen
tissu
confirm
malditof
mass
spectrometrybas
method
allow
rapid
minut
assess
characterist
complement
ribosom
protein
isol
provid
specieslevel
identif
mani
case
microbi
coloni
form
spot
onto
maldi
plate
matrix
compound
load
onto
mass
spectrophotomet
topic
review
great
detail
briefli
laser
focus
onto
samplematrix
spot
caus
sublim
ioniz
migrat
time
flight
tube
detect
mass
spectromet
ms
readout
spectrum
peak
repres
mass
charg
ratio
mz
differ
analyt
mass
rang
approxim
kda
highli
enrich
ribosom
protein
make
larg
share
typic
maldi
spectra
clinic
instrument
spectra
compar
curat
databas
result
return
along
metric
describ
strength
identif
technolog
wide
adopt
europ
gradual
enter
clinic
microbiolog
lab
unit
state
current
two
us
food
drug
administr
fda
approv
system
vitek
ms
durham
north
carolina
maldi
biotyp
bruker
dalton
inc
billerica
massachusett
although
technolog
behind
two
system
essenti
equival
differ
curat
librari
softwar
identif
algorithm
score
system
exampl
vitek
ms
report
isol
confid
valu
wherea
biotyp
return
score
rang
applic
score
greater
necessari
speci
level
identif
difficult
directli
compar
result
two
system
sever
studi
use
platform
back
back
one
studi
larg
collect
strain
bacteria
yeast
mold
demonstr
compar
perform
although
note
librari
coverag
test
cohort
greater
biotyp
strain
vitek
ms
vitek
like
output
misidentif
strain
repres
librari
fdaapprov
applic
vitek
ms
bruker
may
use
larg
librari
aerob
gramneg
gramposit
organ
well
sever
anaerob
yeast
gener
perform
report
equal
exceed
tradit
biochem
system
although
seem
stronger
gramneg
gramposit
organ
lacklust
perform
particular
note
sever
gramposit
rod
studi
biotyp
system
unabl
identifi
sever
isol
nocardia
tsukamurella
kocuria
gordonia
although
listeria
rhodococcu
correctli
classifi
member
corynebacteria
lactobacillu
listeria
also
seem
present
difficulti
term
difficulti
discrimin
speci
requir
lower
score
cutoff
specieslevel
identif
similar
studi
use
vitek
platform
also
report
problem
speciat
listeria
misidentif
kocuria
corynebacterium
also
report
among
gramposit
gramneg
organ
malditof
sever
wellcharacter
difficulti
discrimin
certain
speci
complex
includ
streptococcu
pneumonia
streptococcu
miti
escherichia
colishigella
member
enterobact
cloaca
complex
final
import
note
biotyp
requir
securityrelev
librari
identif
organ
francisella
tularensi
burkholderia
pseudomallei
brucella
spp
maldi
rapidli
becom
method
choic
identifi
anaerob
bacteria
sever
studi
use
larg
divers
collect
anaerob
demonstr
strong
perform
biotyp
vitek
ms
one
recent
multicent
trial
bring
togeth
anaerob
isol
analysi
vitek
ms
isol
correctli
identifi
speci
level
notabl
difficulti
identifi
fusobacterium
nucleatum
identifi
correctli
system
also
show
lower
perform
certain
speci
bacteroid
actinomyc
prevotella
similarli
studi
use
biotyp
platform
identifi
anaerob
isol
blood
cultur
strain
correctli
identifi
speci
level
use
score
genu
level
fusobacterium
spp
problemat
correctli
identifi
speci
level
formic
acidethanol
pretreat
number
increas
addit
nonfragili
bacteroid
spp
misidentifi
bacteroid
high
confid
score
gramposit
anaerob
cocci
correctli
identifi
speci
level
latter
mostli
function
poor
perform
sever
speci
peptoniphilu
interestingli
dedic
studi
look
perform
biotyp
collect
isol
bacteroid
spp
correctli
identifi
speci
level
identif
yeast
fdaapprov
applic
biotyp
vitek
ms
system
demonstr
strong
perform
multipl
studi
review
cassagn
et
al
one
recent
studi
biotyp
exampl
use
librari
clinic
isol
repres
divers
array
yeast
found
agreement
standard
method
addit
isol
biotyp
return
result
confirm
true
sequenc
biotyp
fail
make
identif
addit
isol
bader
et
al
use
even
larger
cohort
clinic
yeast
isol
compar
perform
tradit
method
bruker
biotyp
vitek
sarami
research
use
databas
found
overal
agreement
method
note
maldi
method
abl
discrimin
speci
tradit
method
could
save
time
money
substanti
recent
chao
et
al
analyz
collect
clinic
yeast
isol
biotyp
vitek
ms
found
biotyp
slightli
outperform
vitek
ms
vs
correctli
identifi
speci
complex
level
compar
rate
two
common
phenotyp
method
phoenix
ybc
vitek
yeast
id
respect
trend
also
observ
mancini
et
al
use
collect
clinic
yeast
isol
includ
candida
relat
speci
noncandida
speci
found
biotyp
identifi
isol
wherea
vitek
ms
identifi
use
standard
commerci
avail
databas
importantli
vitek
ms
much
higher
rate
misidentif
vs
gener
found
formic
acidethanol
organ
question
benefit
maldi
routin
clinic
microbiolog
includ
low
cost
reagent
less
product
wast
materi
reduc
consum
shortcom
technolog
part
maldi
limit
cultur
isol
although
offer
tremend
tat
advantag
inher
limit
time
growth
organ
spars
databas
coverag
certain
phyla
eg
filament
fungi
anaerob
present
issu
case
although
commerci
avail
librari
continu
expand
anoth
major
caveat
maldi
yet
practic
method
assess
antibiot
resist
direct
detect
resistanceconf
enzym
practic
within
assay
limit
detect
howev
promis
studi
publish
look
abil
maldi
detect
breakdown
product
incub
presenc
antibiot
howev
resist
test
unlik
incorpor
standard
maldi
microbi
identif
platform
near
futur
mass
spectroscopi
appli
human
tissu
includ
ffpe
varieti
purpos
date
commerci
avail
routin
method
use
ms
detect
organ
ffpe
advent
rapid
inexpens
nucleic
acid
method
ffpe
field
larg
lie
dormant
although
incred
potenti
detect
data
extract
ffpe
ms
may
possibl
futur
year
wide
spectrum
assay
base
detect
nucleic
acid
develop
diagnost
infecti
diseas
rang
simpl
probe
qualit
quantit
target
amplif
sequenc
exampl
first
nucleic
acid
probebas
assay
launch
test
legionnair
diseas
genprob
realtim
platform
smartcycl
lightcycl
establish
place
detect
quantif
pathogen
although
major
impact
mostli
virolog
nucleic
acidbas
techniqu
quickli
adopt
overcom
difficulti
inher
viral
cultur
exampl
hepat
c
viru
hcv
hiv
viral
load
routin
applic
technolog
number
newer
nucleic
acidbas
technolog
tremend
impact
microbi
diagnost
mani
also
gear
toward
bacteri
pathogen
includ
highli
sensit
probe
use
direct
specimen
altern
amplif
method
rapid
assay
singl
target
multiplex
system
allow
detect
mani
organ
one
assay
sequenc
assay
becom
commonplac
target
rang
rrna
whole
genom
even
metagenom
studi
look
makeup
complex
microbi
ecosystem
within
human
host
section
technolog
behind
sever
import
new
assay
briefli
introduc
follow
discuss
applic
clinic
syndrom
respiratori
gastrointestin
gi
diseas
bloodstream
infect
mening
reproduct
healthsexu
transmit
diseas
probe
hybrid
assay
one
earliest
diagnost
techniqu
use
nucleic
acid
target
commonli
use
probe
market
holog
genprob
inc
marlborough
extract
method
lower
ident
cutoff
ie
biotyp
optim
analysi
yeast
although
fdaapprov
applic
maldi
tremend
promis
identif
mycobacteria
alreadi
prefer
identif
method
choic
organ
clinic
laboratori
caveat
includ
need
enhanc
sampl
prepar
method
effici
cell
breakag
biosafeti
reason
ensur
highqual
spectra
sever
studi
shown
promis
result
use
biotyp
equip
mycobacteri
librari
version
vitek
ms
isol
identifi
correctli
speci
level
bruker
subsequ
releas
new
version
mycobacteri
librari
version
contain
differ
speci
reportedli
demonstr
high
perform
correct
identif
speci
level
group
clinic
sampl
version
biotyp
mycobacteri
librari
also
describ
rodriguezsanchez
et
al
found
identif
speci
level
group
nontuberculosi
mycobacteria
great
deal
interest
identif
fungi
yeast
maldi
also
fdaapprov
applic
concern
group
includ
effici
cell
lysi
also
need
higherqu
refer
databas
studi
assess
biotyp
vitek
ms
platform
fungal
isol
use
commerci
avail
databas
iriart
et
al
analyz
group
clinic
isol
vitek
ms
yeast
aspergillu
found
isol
correctli
identifi
includ
aspergillu
compar
respect
routin
laboratori
method
author
limit
studi
speci
present
databas
aspergillu
isol
correctli
identifi
anoth
studi
vitek
ms
abl
correctli
discrimin
close
relat
aspergillu
speci
aspergillu
fumigatu
aspergillu
lentulu
schulthess
et
al
prospect
studi
isol
use
biotyperfilament
fungi
librari
achiev
speci
genu
level
identif
particularli
poor
perform
note
mucor
scopulariposi
chen
et
al
evalu
clinic
mold
isol
biotyp
found
sever
identifi
identifi
low
score
twentyeight
isol
penicillium
marneffei
identifi
due
lack
refer
spectra
databas
howev
rate
identif
went
singl
p
marneffei
spectrum
ad
databas
result
consist
number
studi
indic
high
perform
maldi
fungal
isol
use
custom
databas
although
use
malditof
microbiolog
lab
confin
part
cultur
organ
sever
studi
explor
feasibl
use
primari
sampl
exampl
use
maldi
directli
posit
blood
cultur
attract
rapid
breadth
detect
possibl
open
system
sampl
process
directli
blood
trivial
yet
fda
approv
major
platform
dedic
process
result
promis
high
clinic
accuraci
promis
applic
includ
direct
analysi
urin
cerebrospin
fluid
csf
although
blood
addit
screen
process
step
requir
summari
malditof
clinic
microbiolog
lab
develop
complement
mani
case
replac
tradit
biochem
diagnosi
bacteria
yeast
shorten
turnaround
time
tat
hour
day
depend
varieti
focus
assay
clinic
microbiolog
lab
anatom
patholog
sampl
queri
one
hand
gene
amplif
target
major
reli
pcr
includ
qualit
quantit
assay
run
realtim
pcr
platform
ie
lightcycl
roch
diagnost
indianapoli
indiana
smartcycl
cepheid
sunnyval
california
target
detect
typic
fluoresc
probe
taqman
singletarget
pcr
appli
fresh
frozen
ffpe
anatom
patholog
larg
rang
microorgan
larg
homebrew
inhous
assay
andor
perform
larg
specialti
refer
lab
due
challeng
control
tissu
valid
complex
interpret
recent
develop
area
base
technolog
innov
conveni
detect
method
instanc
sensit
exampl
use
standard
realtim
pcr
technolog
fdaapprov
assay
prodess
kit
holog
genprob
provid
conveni
detect
small
set
respiratori
virus
xpert
system
cepheid
larg
impact
clinic
lab
due
eas
use
sampletoresult
platform
excel
perform
rapid
tat
approxim
hour
detect
melt
curv
analysi
rather
fluoresc
platform
offer
varieti
cartridg
eg
c
difficil
mrsa
mtbrif
focus
quick
answer
major
clinic
decis
point
newer
assay
cepheid
develop
ffpe
includ
microbiolog
applic
novel
detect
method
increas
sensit
platform
biosystem
lexington
massachusett
one
innov
technolog
complet
sampletoresult
platform
reli
detect
pathogenspecif
amplicon
hybrid
tag
superparamagnet
particl
panel
biosystem
fdaapprov
system
directli
analyz
blood
without
cultur
demonstr
impress
result
clinic
trial
sensit
tat
biosystem
current
develop
bacteri
panel
well
report
target
acinetobact
baumannii
e
faecium
k
pneumonia
p
aeruginosa
sa
although
pcr
remain
common
mean
nucleic
acid
amplif
technolog
develop
address
presenc
singl
target
transcriptionmedi
amplif
tma
appli
mycobacteria
hcv
e
coli
listeria
rna
bound
target
oligo
act
upon
sequenc
revers
transcriptas
rt
produc
cdna
rnase
h
degrad
rna
templat
rt
produc
doublestrand
dna
promot
sequenc
rna
polymeras
produc
mani
copi
singlestrand
rnathen
process
repeat
anoth
isotherm
reaction
occur
loopmedi
isotherm
amplif
use
group
four
six
primer
bst
dna
polymeras
creation
complimentari
site
gener
exponenti
amplifi
loop
structur
assay
develop
wide
rang
target
produc
larger
quantiti
dna
tradit
pcr
matter
minut
hour
techniqu
appli
virus
bacteria
protist
fungi
mycobacteria
point
care
manner
lamp
techniqu
limit
challeng
complex
primer
design
limit
abil
multiplex
common
inhibitor
enzym
certain
human
sampl
includ
blood
last
isotherm
amplif
massachusett
consist
singlestrand
dna
probe
tag
acridinium
ester
hybrid
rrna
test
read
luminomet
amplif
probebas
assay
gener
suffer
low
sensit
reserv
cultur
confirm
organ
present
high
number
advandx
woburn
massachusett
produc
seri
probebas
assay
use
peptid
nucleic
acid
pna
probe
tag
fluoresc
marker
pna
probe
sever
advantag
tradit
dna
probe
increas
stabil
abil
penetr
bacteri
cell
wall
fluoresc
tag
ad
advantag
allow
multicolor
detect
creation
limit
panel
rapid
assay
less
hour
mostli
target
toward
rapid
diagnost
posit
blood
cultur
bottl
situ
hybrid
ish
epstein
barr
encod
region
confirm
epsteinbarr
viru
infect
ffpe
routin
use
cancer
diagnost
common
viral
infect
confirm
way
ihc
prefer
applic
rnaish
aspergillu
candida
ffpe
show
less
sensit
realtim
pcr
sequenc
gold
standard
although
fishposit
pcrneg
case
obviou
fungal
element
seen
suggest
refin
techniqu
may
valuabl
rapid
identif
common
organ
especi
mucormycosi
differenti
uniqu
probebas
approach
nucleic
acid
detect
rna
hybrid
digit
count
technolog
offer
nanostr
seattl
washington
method
use
captur
probe
usual
specif
report
probe
second
adjac
specif
attach
uniqu
molecular
color
barcod
bind
individu
molecul
rna
sampl
captur
solid
state
matrix
use
digit
imag
count
barcod
sampl
current
version
measur
independ
captur
report
pair
technolog
appli
rna
target
human
microbi
great
advantag
infecti
diseas
extrem
low
input
quantiti
detect
without
interfer
rna
count
algorithm
proper
probe
select
given
mixtur
accur
quantif
rna
possibl
without
amplif
one
pitfal
technolog
presenc
given
target
disproportion
ratio
target
flood
digit
analysi
ie
consid
hemoglobin
rel
cytokin
peripher
blood
rel
sequenc
technolog
remain
expens
benefit
quantif
extrem
limit
sampl
minim
process
make
attract
target
futur
test
develop
microorgan
broad
panel
use
signatur
gene
andor
focus
panel
use
gene
antibiot
metabol
pathway
creat
studi
rang
diseas
shown
rna
sourc
includ
ffpe
suffici
nanostr
analysi
one
studi
quantit
express
plasmodium
falciparum
schizont
human
tissu
frozen
ffpe
measur
use
imput
entir
express
profil
organ
determin
pathogen
includ
e
coli
shigella
salmonella
campylobact
clostridium
perfringen
typic
viral
pathogen
includ
panel
adenoviru
noroviru
rotaviru
repres
three
common
symptomat
viral
diarrhea
diagnosi
move
toward
multiplex
panel
cover
major
bacteri
pathogen
well
parasit
viral
agent
addit
standard
agent
infecti
diarrhea
special
consider
test
diseas
caus
c
difficil
panel
extrem
valuabl
tool
diagnos
diseas
anatom
patholog
often
limit
invas
patient
situat
parasit
enter
infect
repres
major
challeng
develop
countri
remain
rare
countri
new
technolog
develop
despit
dispar
situat
effort
made
approach
parasit
infect
thu
inher
challeng
becom
appar
extract
stool
suspect
parasit
infect
requir
protist
ciliat
ameoba
flagel
coccidia
helminth
larva
nematod
helminth
egg
nematod
trematod
cestod
lyse
suffici
releas
dna
effici
challeng
led
eight
differ
extract
protocol
rang
prepar
requir
includ
spin
column
autom
magnet
bead
assay
bead
beat
method
molecular
target
subsequ
detect
assay
specif
singl
target
across
rang
organ
includ
rdna
cox
rdna
segment
cowp
actin
rdna
commerci
avail
multiplex
pcr
assay
major
platform
target
cryptosporidium
giardia
entamoeba
histolytica
rare
cyclospora
first
three
repres
parasit
isol
method
stool
develop
nation
addit
much
less
common
pathogen
common
inclus
nonpathogen
ameba
common
assay
question
valu
genitourinari
sampl
fluid
cervic
sampl
urethr
swab
anoth
sampl
benefit
multiplex
test
public
health
screen
sexual
transmit
diseas
extrem
valuabl
individu
patient
diagnosi
well
epidemiolog
survey
especi
inclus
hiv
neisseria
gonorrhea
chlamydia
trachomati
hpv
holog
panther
system
perform
singl
sampl
system
also
test
trichomona
filmarray
biofir
salt
lake
citi
utah
detect
chlamydia
neisseria
syphili
trichomona
mycoplasmaureaplasma
herp
simplex
chancroid
singl
sampl
although
rel
uncommon
mening
enceph
nosocomi
communityacquir
carri
high
morbid
mortal
time
essenc
diagnos
caus
agent
particularli
tri
determin
whether
bacteri
pathogen
need
immedi
antibiot
coverag
along
herp
simplex
need
immedi
antivir
common
bacteri
pathogen
includ
pneumonia
streptococcu
agalactia
neisseria
meningitidi
haemophilu
influenza
listeria
monocytogen
although
also
sever
less
frequent
isol
pathogen
viral
pathogen
panel
includ
primari
action
virus
cytomegaloviru
herp
simplex
varicella
zoster
viru
well
common
virus
enteroviru
parechoviru
human
herpesviru
hhv
platform
also
may
includ
cryptococcu
speci
fungi
valuabl
immunosuppress
popul
current
diagnost
heavili
focus
csf
biochem
profil
glucos
protein
lactat
cell
count
gram
stain
latter
specif
limit
detect
approxim
accomplish
introduct
helicas
unwind
dna
singlestrand
dna
bind
protein
keep
templat
separ
follow
primer
hybrid
amplif
produc
singlestrand
dna
thu
continu
reaction
assay
measur
herp
simplex
viru
hsv
use
helicas
develop
similar
perform
tradit
molecular
method
assay
avail
bordetella
group
streptococcu
trichomona
malaria
commonli
use
platform
use
technolog
includ
tigri
panther
system
genprob
base
tma
smmitlamp
base
lamp
amplivu
base
helicas
use
assay
ffpe
tissu
shown
promis
improv
perform
pcr
organ
hcv
tma
equival
perform
pcr
human
papillomaviru
hpv
head
neck
cancer
lamp
detect
limit
signatur
microcarcinoma
small
biopsi
helicas
assay
abil
detect
multipl
organ
primari
sampl
use
pcrbase
panel
provid
clinician
tremend
diagnost
opportun
present
new
challeng
major
platform
includ
filmarray
verigen
nanospher
xtagxmap
luminex
austin
texa
technolog
rang
realtim
pcr
solid
liquid
phase
array
comprehens
list
platform
see
wwwcaptodayonlinecom
productguid
indepth
discuss
major
technolog
see
articl
includ
refer
list
system
gener
gear
toward
syndrom
test
panel
direct
toward
respiratori
gi
sexual
transmit
diseas
well
mening
bloodstream
infect
discuss
specif
challeng
major
syndrom
section
focu
commonli
use
fdaapprov
panel
current
avail
number
manufactur
scan
wide
array
microb
encompass
viral
bacteri
fungal
organ
panel
aim
respiratori
pathogen
focus
heavili
virus
also
incorpor
sever
bacteri
agent
commonli
cover
organ
includ
mycoplasma
pneumonia
chlamydia
pneumonia
bordetella
speci
pneumonia
c
pneumonia
common
caus
communityacquir
pneumonia
particularli
wellsuit
nucleic
acid
amplif
test
difficult
cultur
although
less
common
bordetella
pertussi
consid
common
vaccineprevent
diseas
unit
state
increas
incid
also
difficult
cultur
bread
butter
respiratori
panel
rp
focu
virus
influenza
b
adenoviru
respiratori
syncyti
viru
rsv
alway
includ
along
mixtur
coronaviru
enteroviru
metapneumoviru
parainfluenza
group
panel
extrem
power
clinician
point
view
also
provid
larger
rang
diagnost
respiratori
virus
found
anatom
patholog
lab
larg
limit
dna
virus
although
viral
diagnos
chemotherapeut
action
confirm
viral
caus
valuabl
prognosi
resourc
alloc
diarrheal
diseas
global
public
health
concern
although
diseas
common
caus
ill
hospit
unit
state
impos
enorm
toll
develop
world
particularli
children
common
bacteri
common
mani
panel
individu
test
laboratori
difficulti
obtain
natur
clinic
case
e
histolytica
current
fdaapprov
multiplex
assay
agent
mening
enceph
filmarray
mening
panel
cover
pathogen
includ
follow
bacteria
e
coli
h
influenza
l
monocytogen
n
meningitid
agalactia
pneumonia
although
panel
recent
approv
fda
octob
report
perform
prefda
evalu
conduct
archiv
sampl
prospect
multicent
collect
sampl
csf
among
archiv
sampl
bacteria
percent
posit
neg
agreement
bacteri
target
among
prospect
sampl
eight
bacteri
pathogen
none
l
monocytogen
n
meningitid
present
filmarray
panel
identifi
agalactia
archiv
arm
evalu
includ
two
agalactia
sampl
correctli
identifi
sinc
fda
approv
one
us
studi
publish
perform
panel
sever
texa
medic
center
studi
patient
communityacquir
mening
neg
gram
stain
filmarray
detect
two
sampl
bacteri
pathogen
pneumonia
cultur
detect
one
although
one
posit
streptococc
urinari
antigen
final
filmarray
blood
cultur
identif
bcid
panel
test
array
bacteri
target
includ
enterococcu
l
monocytogen
sa
streptococcu
multipl
baumannii
p
aeruginosa
e
coli
k
pneumonia
also
test
five
speci
candida
three
bacteri
resist
gene
meca
vanab
kpc
perform
well
monomicrobi
polymicrobi
specimen
sever
clinic
studi
bd
max
sampletoresult
realtim
pcrbase
platform
amplicon
detect
via
fluoresc
probe
distinguish
featur
capabl
run
laboratorydevelop
test
alongsid
fdaapprov
panel
current
fdaapprov
assay
includ
gb
group
b
streptococci
ctgctv
vagin
mrsa
xt
extend
mrsa
coverag
cdiff
c
difficil
staffsr
staphylococcu
aurea
mrsa
bacteri
panel
includ
salmonella
spp
campylobact
spp
jejunicoli
shigellosi
diseasecaus
agent
shigella
spp
eiec
well
shigatoxin
produc
e
coli
demonstr
high
sensit
organ
librari
sever
studi
parasit
panel
includ
three
common
protist
parasit
human
develop
countri
includ
giardia
lamblia
cryptosporidium
e
histolytica
difficult
challeng
low
popul
preval
rel
bacteri
assay
make
cost
challeng
method
uptak
verigen
anoth
wide
use
multiplex
pcr
platform
incorpor
pcr
multipl
viral
bacteri
target
follow
hybrid
solidphas
microarray
detect
occur
via
sandwich
hybrid
anoth
analytespecif
probe
bound
gold
nanoparticl
signal
amplifi
via
deposit
colloid
silver
detect
light
diffract
verigen
organ
per
millilit
great
need
rapid
molecular
diagnost
area
anatom
patholog
sampl
cultur
andor
morpholog
special
stain
andor
ihc
resolv
mani
infect
howev
optim
patient
care
best
outcom
occur
patient
diagnos
earli
panel
requir
invas
biopsi
sepsi
continu
tremend
caus
mortal
rank
one
top
caus
death
unit
state
organ
commonli
associ
bloodstream
infect
includ
sa
e
coli
enterococcu
spp
k
pneumonia
cn
p
aeruginosa
candida
albican
e
cloaca
serratia
marcescen
current
gold
standard
diagnosi
cultur
sever
autom
system
bactalert
inc
avail
clinic
laboratori
although
system
quit
sensit
approxim
onethird
patient
sepsi
posit
cultur
lack
sensit
may
due
pretreat
antibiot
may
due
low
number
organ
present
mani
clinic
signific
bacteremia
addit
sensit
speed
also
major
issu
rapid
diagnosi
bloodstream
infect
critic
patient
outcom
estim
decreas
surviv
everi
hour
appropri
antimicrobi
delay
onset
hypotens
need
sensit
fast
detect
ideal
accompani
assess
antibiot
resist
determin
inspir
number
new
technolog
gear
toward
improv
speed
sensit
blood
cultur
diagnost
sever
review
platform
technolog
filmarray
filmarray
system
consist
nest
pcr
follow
highresolut
melt
curv
analysi
step
assay
cell
lysi
final
analysi
take
place
within
pouch
contain
freezedri
reagent
store
room
temperatur
filmarray
short
tat
approxim
hour
disadvantag
system
includ
rel
high
price
pouch
restrict
platform
one
test
time
laboratori
must
purchas
multipl
filmarray
platform
desir
run
test
parallel
filmarray
panel
first
fdaapprov
rp
includ
bacteri
pathogen
cover
b
pertussi
c
pneumonia
pneumonia
along
common
respiratori
virus
gi
test
filmarray
comprehens
current
fdaapprov
panel
cover
array
bacteria
viral
parasit
target
includ
common
agent
list
well
plesiomona
shigelloid
yersinia
enterocolitica
sever
speci
vibrio
also
differenti
enteroaggreg
enteropathogen
enterotoxigen
shiga
toxinproduc
enteroinvas
e
coli
eiec
studi
shown
sensit
specif
bacteri
pathogen
mani
case
filmarray
detect
pathogen
sampl
neg
far
like
diagnos
mix
infect
standard
techniqu
viral
pathogen
filmarray
gi
panel
shown
valu
younger
age
group
patient
younger
year
test
pathogen
sensit
specif
wherea
noroviru
appear
valuabl
across
age
group
sensit
specif
perform
parasit
pathogen
panel
equal
high
cryptosporidium
cyclospora
giardia
sensit
specif
vibrio
cholera
enterocolitica
one
studi
compar
xtag
filmarray
convent
techniqu
two
platform
behav
compar
xtag
slightli
trail
filmarray
diagnosi
mix
infect
filmarray
vs
xtag
vs
routin
test
perform
xtag
viral
pathogen
compar
realtim
rtpcr
multiplex
realtim
rtpcr
show
wide
variat
sensit
across
virus
xtag
perform
rsva
rsvb
influenza
b
respect
headtohead
comparison
filmarray
esensor
rvp
xtag
three
method
essenti
equival
xtag
best
perform
influenza
caveat
xtag
system
address
newer
luminex
platform
ari
sampletoresult
platform
test
primari
clinic
specimen
assay
consist
realtim
pcr
use
luminex
multicod
technolog
system
use
primer
incorpor
isobas
isoc
isog
incorpor
pair
one
isobas
tag
fluoresc
report
tag
quencher
upon
success
gener
product
isobas
incorpor
fluoresc
decreas
subsequ
melt
curv
analysi
perform
fluoresc
restor
unlik
xtag
technolog
multicod
run
either
commerci
avail
realtim
pcr
system
within
sampletoresult
ari
platform
bd
one
fdaapprov
test
panel
panel
use
test
cutan
mucocutan
lesion
although
nucleic
acidbas
system
describ
demonstr
high
level
sensit
specif
inher
limit
select
group
organ
base
probeprim
set
contain
open
assay
use
broadrang
primer
target
nearli
univers
sequenc
nearli
base
discoveri
carl
woes
rrna
subunit
could
use
determin
phylogenet
structur
domain
life
although
idea
repres
fundament
shift
bacteriolog
took
mani
year
wide
accept
even
longer
use
rrna
sequenc
use
standard
mean
identifi
bacteria
clinic
laboratori
howev
sinc
becom
gold
standard
determin
bacteri
speci
analysi
led
great
deal
restructur
renam
among
phyla
briefli
gene
encod
portion
small
ribosom
subunit
compos
nine
variabl
region
altern
nine
conserv
region
fig
gene
sequenc
use
primer
bind
highli
conserv
region
compar
refer
databas
identifi
isol
choic
databas
typic
challeng
part
assay
number
databas
use
identifi
sequenc
rang
larg
public
uncur
partial
curat
databas
genbank
ribosom
databas
project
rdp
univers
michigan
commerci
highli
curat
collect
much
limit
scope
identif
algorithm
includ
ripseq
pathogenomix
santa
cruz
california
integr
databas
network
system
tat
approxim
hour
advantag
offer
flexibl
price
laboratori
charg
test
request
instead
entir
panel
disadvantag
includ
need
select
appropri
cartridg
base
gram
stain
result
bloodstream
diagnost
respiratori
gi
bloodstream
panel
avail
verigen
platform
detect
respiratori
virus
high
sensit
includ
multipl
type
influenza
parainfluenza
three
bordetella
speci
b
pertussi
bordetella
parapertussi
bordetella
bronchiseptica
bordetella
holmesii
although
one
advantag
system
flexibl
test
limit
panel
base
given
popul
gi
panel
somewhat
limit
filmarray
cover
target
includ
bacteria
virus
parasit
bacteria
includ
campylobact
group
salmonella
spp
shigella
spp
vibrio
group
enterocolitica
well
shiga
toxin
one
studi
stool
sampl
verigen
demonstr
agreement
rate
cultur
diagnosi
bloodstream
infect
verigen
system
separ
cartridg
gramposit
gramneg
organ
necessit
accur
gram
stain
pick
appropri
test
make
polymicrobi
test
bit
complic
panel
assess
extra
organ
filmarray
singl
panel
addit
gramneg
panel
queri
sever
resist
target
filmarray
includ
ctxm
imp
ndm
oxa
vim
verigen
rp
excel
perform
influenza
virus
b
includ
abil
subtyp
virus
perfect
agreement
gold
standard
method
molecular
howev
mix
infect
noninfluenza
virus
dampen
perform
headtohead
comparison
limit
verigen
panel
influenza
b
rsv
filmarray
rp
show
equival
detect
three
major
pathogen
slightli
reduc
cost
verigen
thu
analysi
clinic
popul
desir
local
clinic
team
report
viru
action
diagnos
may
help
choos
technolog
xtag
xtag
assay
system
luminex
liquid
array
base
multiplex
pcr
follow
amplicon
extens
use
targetspecif
primer
extens
step
incorpor
hybrid
tag
onto
amplicon
along
biotin
label
elong
tag
amplicon
incub
polystyren
microbead
variou
fluoresc
profil
coat
specif
antitag
sequenc
beadamplicon
pair
stain
anoth
streptavidinlink
fluorophor
bead
analyz
system
two
laser
xmap
instrument
first
determin
bead
bound
amplicon
way
streptavidinfluorophor
second
laser
indic
specif
target
amplifi
way
uniqu
fluoresc
bound
bead
although
luminex
platform
gener
potenti
detect
greatest
number
target
drawback
includ
need
separ
nucleic
acid
extract
step
longer
tat
hour
longer
multiplex
platform
two
xtag
platform
focus
respiratori
test
origin
xtag
platform
restrict
viral
pathogen
nextgener
system
nxtag
includ
sever
bacteri
pathogen
well
includ
legionella
pneumophila
xtag
gastrointestin
pathogen
panel
gpp
test
nine
bacteri
three
viral
three
parasit
target
among
bacteri
loci
luminex
xtag
cover
campylobact
c
difficil
toxin
ab
e
coli
enterotoxigen
e
coli
etec
ltst
shiga
toxinproduc
e
coli
stec
salmonella
shigella
sanger
sequenc
gener
unabl
assess
polymicrobi
infect
although
analysi
softwar
packag
algorithm
deconvolut
trace
two
three
differ
organ
ng
highthroughput
method
gener
refer
massiv
parallel
process
gener
tremend
quantiti
raw
sequenc
read
number
commerci
avail
platform
vari
quantiti
qualiti
length
read
produc
major
includ
step
clonal
amplif
templat
produc
short
bp
read
excel
review
see
articl
provid
refer
list
advent
ng
groundbreak
event
clinic
medicin
key
compon
initi
precis
medicin
cancer
beyond
human
genom
analysi
ng
also
tremend
influenc
clinic
microbiolog
extend
infecti
diseas
test
epidemiolog
analysi
human
microbiom
health
diseas
intervent
within
diagnost
clinic
microbiolog
laboratori
ng
microbi
whole
genom
appli
altern
tradit
method
pulsedfield
gel
electrophoresi
clonal
analysi
outbreak
track
refin
made
possibl
total
chromosom
singlenucleotid
polymorph
analysi
exampl
allow
one
group
assess
spread
variant
colon
popul
carbapenemresist
k
pneumonia
one
patient
sever
other
multipl
transmiss
event
variant
differenti
fewer
dozen
nucleotid
applic
becom
routin
includ
character
unusu
pathogen
track
antibiot
resist
gene
even
character
plasmid
carri
horizont
gene
transfer
although
yet
routin
ng
use
diagnos
infect
directli
primari
sampl
case
convent
techniqu
fail
one
report
month
progress
neurolog
symptom
thorough
unrev
infecti
diseas
workup
ng
final
abl
diagnos
case
neuroleptospirosi
directli
csf
boy
addit
detect
character
pathogen
ng
also
proven
invalu
tool
character
human
microbiom
influenc
microbiom
human
health
diseas
becom
progress
establish
exampl
mani
includ
develop
obes
metabol
therapeut
drug
develop
inflammatori
bowel
diseas
two
common
way
assess
microbiom
rrna
shotgun
metagenom
ng
analysi
entail
sequenc
one
portion
rrna
mix
commun
eg
stool
sampl
subsequ
cluster
sequenc
either
refer
dataset
oper
taxonom
unit
otu
give
pictur
taxonom
divers
sampl
allow
analysi
chang
taxonom
composit
face
variou
perturb
intervent
antibiot
administr
shotgun
metagenom
refer
sequenc
total
dna
mix
commun
techniqu
allow
refin
organ
identif
analysi
biochem
pathway
resist
gene
etc
requir
greater
amount
raw
sequenc
idn
smartgen
raleigh
north
carolina
microseq
appli
biosystem
thermofish
waltham
massachusett
first
two
product
sole
bioinformat
refer
solut
last
includ
reagent
access
curat
databas
none
product
fda
approv
clinic
laboratori
standard
institut
clsi
publish
guidelin
identif
organ
nucleic
acid
sequenc
recommend
percentag
ident
make
match
guidanc
organ
requir
addit
target
eg
rpob
accur
speciat
laid
forth
use
clinic
microbiolog
laboratori
shown
particularli
use
applic
identif
unusu
andor
slowgrow
organ
identif
organ
specimen
cultur
possibl
fail
specimen
antibiotictr
patient
fix
specimen
exampl
identif
mycobacteri
speci
identifi
acidfast
stain
ffpe
commonli
use
applic
sequenc
although
addit
target
often
need
differenti
speci
specimen
type
success
analyz
direct
includ
heart
valv
csf
synovi
fluid
fungal
pathogen
also
identifi
use
rrna
sequenc
although
less
establish
practic
bacteri
target
fungal
rrna
correspond
bacteri
although
fewer
hypervari
region
gener
use
isol
discrimin
common
region
fungal
identif
region
well
hypervari
region
rrna
larg
subunit
compon
fig
use
target
identifi
isol
criteria
requir
percentag
ident
percentag
differ
compet
match
clear
fungi
bacteria
lack
highqual
databas
major
difficulti
fungal
sequenc
estim
entri
genbank
incorrectli
identifi
speci
level
address
sever
privat
databas
avail
bacteri
sequenc
also
includ
curat
partial
curat
fungal
databas
idn
ripseq
microseq
system
also
includ
fungal
compon
limit
region
recent
sever
public
databas
becom
avail
highqual
curat
content
databas
focus
speci
medic
import
includ
intern
societi
human
anim
mycolog
isham
databas
contain
sequenc
repres
human
anim
pathogen
fungal
speci
major
resourc
clinic
laboratori
search
via
webbas
platform
itsmycologylaborg
nation
center
biotechnolog
inform
refseq
databas
contain
sequenc
repres
famili
class
smaller
refseq
databas
contain
approxim
repres
greater
famili
class
techniqu
particularli
promis
identifi
fungi
fix
tissu
import
caveat
rrna
sequenc
includ
high
cost
complex
issu
uncur
databas
describ
potenti
fals
posit
particularli
case
broadrang
sequenc
appli
primari
specimen
fish
infecti
agent
absenc
corrobor
cultur
gram
stain
furthermor
rrna
use
determin
whether
infect
clear
due
potenti
linger
nucleic
acid
even
success
treat
infect
analysi
restrict
normal
steril
site
test
use
ffpe
organ
seen
identifi
bacteria
fungal
element
viral
cytopath
necrot
effect
unidentifi
parasit
element
ng
enorm
potenti
rectifi
these
diagnos
current
limit
cost
per
sampl
enorm
amount
raw
human
data
comparison
rel
small
amount
organ
sequenc
cost
fall
sequenc
rapid
bioinformat
method
elucid
caus
sequenc
emerg
ng
becom
primari
tool
confirm
microbi
infect
one
last
technolog
consid
hybrid
system
plexid
abbott
combin
pcr
step
amplifi
set
primer
plexid
viral
ic
plexid
bac
spectrum
bc
plexid
flu
broad
rang
organ
detect
pcr
product
mass
spectroscopi
approach
combin
amplif
mani
sampl
type
includ
bodi
fluid
tissu
ffpe
cultur
isol
blood
highli
sensit
detect
system
make
subtl
speci
determin
across
organ
type
includ
bacteri
fungal
viral
parasit
databas
spectra
improv
multiplex
primer
improv
system
gain
popular
although
still
limit
initi
organ
burden
procedur
time
hour
microbiolog
laboratori
remain
import
companion
anatom
pathologist
potenti
infecti
diagnosi
microscop
anecdot
small
studi
demonstr
yield
molecular
test
perform
blindli
without
visual
versu
pathologist
review
miniscul
extrem
expens
therefor
anatom
pathologist
microbiolog
colleagu
must
constant
line
commun
moment
specimen
collect
final
report
ensur
interpret
modal
maxim
benefici
patient
care
dialogu
also
includ
discuss
molecular
modal
appli
clinic
anatom
patholog
specimen
chang
advantag
pitfal
benefit
modal
everevolv
manner
approach
medicin
evidencebas
use
effici
inexpens
method
produc
highestimpact
result
patient
constant
goal
